Literature DB >> 7551590

Psychological interventions in infection with the human immunodeficiency virus.

J Catalan1.   

Abstract

BACKGROUND: Infection with the human immunodeficiency virus (HIV) is associated with substantial psychiatric morbidity. This paper summarises the main forms of psychological intervention currently used, and reviews research evidence for their efficacy.
METHOD: Publications on the mental health aspects of HIV infection and psychological interventions were identified through the main HIV journals and general psychiatric and psychological periodicals, with the assistance of AIDS Abstracts.
RESULTS: Publications concerned psychological interventions at the time of HIV testing, interventions for infected people at different stages of disease, and risk-reduction interventions. While many publications were identified describing uncontrolled investigations, only a few studies had involved systematic evaluative research.
CONCLUSIONS: There is a need for systematic evaluation of psychological interventions for HIV infection, in terms of both efficacy and cost.

Entities:  

Mesh:

Year:  1995        PMID: 7551590     DOI: 10.1192/bjp.167.1.104

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  3 in total

1.  Towards a family-centered approach to HIV treatment and care for HIV-exposed children, their mothers and their families in poorly resourced settings.

Authors:  Tamsen Jean Rochat; Ruth Bland; Hoosen Coovadia; Alan Stein; Marie-Louise Newell
Journal:  Future Virol       Date:  2011-06       Impact factor: 1.831

Review 2.  Lipodystrophy syndrome in patients with HIV infection: quality of life issues.

Authors:  E Martínez; M A Garcia-Viejo; L Blanch; J M Gatell
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

3.  A study of psychiatric manifestations of physically asymptomatic hiv - I seropositive individuals.

Authors:  R Satapathy; M N Krishna; A M Babu; M Vijayagopal
Journal:  Indian J Psychiatry       Date:  2000-10       Impact factor: 1.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.